Amgen

💰 $28,500,000,000 Post-IPO Debt about 2 years ago🫂 Last layoff over 1 year agoBiotechnology Research
Website LinkedIn Email Facebook Twitter

Amgen is a biotechnology company that specializes in developing and manufacturing human therapeutics for a wide range of diseases. They are committed to using science and innovation to create transformative medicines for patients with serious illnesses.

Related companies: